Page last updated: 2024-08-17

propoxycaine and Age-Related Macular Degeneration

propoxycaine has been researched along with Age-Related Macular Degeneration in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barouch, FC; Blaha, GR; Marx, JL; Tilton, EP1
Rifkin, L; Schaal, S1

Trials

2 trial(s) available for propoxycaine and Age-Related Macular Degeneration

ArticleYear
Randomized trial of anesthetic methods for intravitreal injections.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:3

    Topics: Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Double-Blind Method; Eye Pain; Female; Humans; Intravitreal Injections; Lidocaine; Macular Degeneration; Male; Pain Measurement; Propoxycaine; Prospective Studies; Ranibizumab; Tetracaine; Vitreous Body

2011
Factors affecting patients' pain intensity during in office intravitreal injection procedure.
    Retina (Philadelphia, Pa.), 2012, Volume: 32, Issue:4

    Topics: Aged; Analysis of Variance; Anesthesia; Anesthetics, Local; Diabetic Retinopathy; Female; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Pain; Pain Measurement; Propoxycaine; Prospective Studies; Retinal Vein Occlusion; Risk Factors; Tetracaine

2012